T/o8 Oct 2020 11:41
Morning all, this is just my personal opinion tho. and a lot of posters will probably shoot me down for this posting, but as things stand I now see us as a takeover target for one of the big pharma companies, we all know that DDDD has more than one bullet in it's gun and at these prices would be an absolute steal to a large pharma. I remember reading one of the posters yesterday who had Crohn's disease (God bless him) saying that a 10% improvement in his lifestyle would be massively significant, but what really caught my eye in the rns was and I quote:
The effect shown by Blautix across both sub-types indicates it may potentially provide a solution to IBS-M patients whose symptoms fluctuate between IBS-C and IBS-D. These patients, who account for around 30% of all IBS patients, currently have no approved treatment options. This reflects the broad potential of Blautix as a completely new, safe, flexible therapeutic approach to treating all forms of the condition.
I know we enter stage 3 and it will take time to come to fruition, but with no other competition out there for IBS-M, what large pharma company wouldn't be rubbing their hands for a piece of the action. OMO, tho, but watch this space, GLA.